|
|
|
Volumn 61, Issue SUPPL. 9, 2000, Pages 3-4
|
|
Fifty years of lithium use in the treatment of bipolar disorder
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTICONVULSIVE AGENT;
LITHIUM;
NEUROLEPTIC AGENT;
ADRENERGIC RECEPTOR AFFECTING AGENT;
MORPHOLINE DERIVATIVE;
NORADRENALIN;
REBOXETINE;
MONOAMINE OXIDASE INHIBITOR;
NORADRENALIN UPTAKE INHIBITOR;
SEROTONIN UPTAKE INHIBITOR;
TRICYCLIC ANTIDEPRESSANT AGENT;
ADVERSE DRUG REACTION;
DIFFERENTIAL DIAGNOSIS;
EDITORIAL;
HUMAN;
MANIC DEPRESSIVE PSYCHOSIS;
PRIORITY JOURNAL;
PSYCHOTHERAPY;
SUICIDAL BEHAVIOR;
ARTICLE;
DEPRESSION;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
SYNAPTIC TRANSMISSION;
DRUG CHOICE;
DRUG EFFICACY;
NEUROTRANSMISSION;
NEUROTRANSMITTER RELEASE;
ADRENERGIC UPTAKE INHIBITORS;
DEPRESSIVE DISORDER;
HUMANS;
MORPHOLINES;
NOREPINEPHRINE;
SYNAPTIC TRANSMISSION;
|
|
EID: 0033947002
PISSN: 01606689
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (2)
|
|
References (1)
|
